Products
| Product Name | CAS No. | Specification | Application | Registration |
| 24, 25-Dihydroxy VD3 | 40013-87-4 | |||
| Osimertinib mesylate | 1421373-66-1 | 98+% | Anti-cancer | EGFR | |
| Osimertinib | 1421373-65-0 | 98+% | Anti-cancer research | EGFR | |
| Retatrutide | 2381089-83-2 | 98+% | Research on Obesity | GLP Receptor | |
| Cagrilintide | 1415456-99-3 | 98+% | Research on the treatment of diabetes | CGRP Receptor | |
| Ruxolitinib phosphate | 1092939-17-7 | 99+% | ||
| Staurosporine | 62996-74-1 | 98+% | Anticancer Research | Antineoplastic and Immunosuppressive Antibiotics inhibitor | PKC inhibitor | |
| Midostaurin | 120685-11-2 | 98+% | Anticancer Research | |
| Hidrosmin | 115960-14-0 | 90+% | Research on Venous Insufficiency and Diabetes | |
| Perilla Leaf Oil | 68153-38-8 | |||
| Azvudine | 1011529-10-4 | 98+% | Reverse Transcriptase | |
| Melatonin | 73-31-4 | 98+% | Ingredient of health care products. | |
| Calicheamicin | 108212-75-5 | 98+% | Tumor antibiotics | |
| N-Acetyl-Calicheamicin | 108212-76-6 | 98+% | Cancer Targeted Therapy | |
| Fludarabine Phosphate | 75607-67-9 | 98+% | DNA/RNA Synthesis inhibitor |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn